Donald Bergstrom
Analyst
Equibles does not estimate personal net worth.
About Donald Bergstrom
Donald Bergstrom has spoken on 1 investor event across 1 company, most recently for Relay Therapeutics, Inc. on June 3, 2026. The companies whose calls Donald Bergstrom spoke on are classified in the Healthcare sector.
Donald Bergstrom on recent calls
“As we're moving into a front-line setting, we have proof today from Roche's and AVO120 trial of inovolacib in an endocrine-resistant patient population, front-line treated, where we saw doubling of PFS and an OS benefit for the triplet regimen of inovolacib with palbo and in fulvestrin versus fulvestrin plus palbo.”